Hospital incidence and medical costs of polycythemia vera in Spain: a retrospective database analysis

Publication date

2022-09-20T11:49:00Z

2023-10-31T06:10:25Z

2022-10

2022-09-20T11:49:00Z

Abstract

Polycythemia vera (PV) is one of the most common chronic myeloproliferative neoplasms, yet, little data is available on the epidemiology of PV in Spain and the costs of its management. This study aimed to evaluate the hospital incidence and mortality rate of PV in Spain, and to estimate hospital medical costs.

Document Type

Article


Accepted version

Language

English

Publisher

Informa Healthcare

Related items

Versió postprint del document publicat a: https://doi.org/10.1080/14737167.2022.2029413

Expert Review of Pharmacoeconomics & Outcomes Research, 2022, vol. 22, num. 6, p. 965-970

https://doi.org/10.1080/14737167.2022.2029413

Recommended citation

This citation was generated automatically.

Rights

(c) Informa Healthcare, 2022

This item appears in the following Collection(s)